The third patient with a SCCOHT tumor phenotype (patient #3) showed a biallelic somatic SMARCA4 inactivation (see supplement for detailed medical cancer history of all three SCCOHT families, including genetic test results). This evidence concerns the gene SMARCA4 and cancer.